Congenital toxoplasmosis. A prospective study of 378 pregnancies.
D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D008722:Methods; D010297:Paris; D010920:Placenta; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology; D011446:Prospective Studies; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology
D000906:Antibodies; D007933:Leucomycins; D013449:Sulfonamides; D011739:Pyrimethamine